Poster: ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia or With T315I Mutation
Clinical Lymphoma Myeloma and Leukemia（2022）
摘要
The study is currently open and enrolling patients and includes ≈70 study sites in ≈16 countries.
更多查看译文
关键词
ALL,leukemia,ponatinib,TKI,T315I
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要